Your browser doesn't support javascript.
loading
Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners.
Li, Bojun; Bechtler, Clément; Jenny, Lorenz; Ricklin, Daniel; Schroeder, Verena.
Affiliation
  • Li B; Experimental Haemostasis Group, Department for BioMedical Research DBMR University of Bern Bern Switzerland.
  • Bechtler C; Molecular Pharmacy Group, Department of Pharmaceutical Sciences University of Basel Basel Switzerland.
  • Jenny L; Experimental Haemostasis Group, Department for BioMedical Research DBMR University of Bern Bern Switzerland.
  • Ricklin D; Molecular Pharmacy Group, Department of Pharmaceutical Sciences University of Basel Basel Switzerland.
  • Schroeder V; Experimental Haemostasis Group, Department for BioMedical Research DBMR University of Bern Bern Switzerland.
Res Pract Thromb Haemost ; 6(5): e12766, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35873217
ABSTRACT

Background:

The factor XIII (FXIII)-B subunit has a critical function as a carrier protein to stabilize FXIII-A in plasma and supply it to its main substrate, fibrinogen. However, the function of the excess free FXIII-B circulating in plasma is still elusive.

Objectives:

In the present study, we explored potential interactions of free FXIII-B with complement factors and searched for novel binding partners.

Methods:

We tested for cofactor activity in the degradation of complement C3b and C4b and used ELISA- and surface plasmon resonance-based binding assays to investigate interactions between FXIII-B and complement components. We performed immunoprecipitation and mass spectrometry analysis to identify potential binding partners of free FXIII-B in freshly drawn plasma samples.

Results:

FXIII-B did not exhibit cofactor activity in the degradation of C3b and C4b similar to factor H and C4b-binding protein, nor did it bind to complement factors to a relevant extent. Identification of proteins potentially binding to free FXIII-B revealed high interindividual variation. We confirmed α2-macroglobulin (α2MG) as a candidate, although direct interactions or functional effects remain to be validated.

Conclusions:

Our study reveals that free FXIII-B has no direct role in regulating the complement system, despite a structural similarity to major complement regulators. Further studies are needed to validate α2MG as a binding partner and explore potential functional consequences of this binding.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Res Pract Thromb Haemost Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Res Pract Thromb Haemost Year: 2022 Type: Article